5 relations: Cebranopadol, Depo, NASDAQ Biotechnology Index, Steven R. Goldstein, Tapentadol.
Cebranopadol
Cebranopadol (developmental code name GRT-6005) is a novel opioid analgesic of the benzenoid class which is currently under development internationally by Grünenthal, a German pharmaceutical company, and its partner Depomed, a pharmaceutical company in the United States, for the treatment of a variety of different acute and chronic pain states.
New!!: Depomed and Cebranopadol · See more »
Depo
Depo may refer to.
New!!: Depomed and Depo · See more »
NASDAQ Biotechnology Index
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals.
New!!: Depomed and NASDAQ Biotechnology Index · See more »
Steven R. Goldstein
Steven R. Goldstein is an inventor, author and a professor of obstetrics and gynecology at NYU School of Medicine.
New!!: Depomed and Steven R. Goldstein · See more »
Tapentadol
Tapentadol (brand names: Nucynta, Palexia and Tapal) is a centrally acting opioid analgesic of the benzenoid class with a dual mode of action as an agonist of the μ-opioid receptor and as a norepinephrine reuptake inhibitor (NRI).
New!!: Depomed and Tapentadol · See more »